You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

06-007

Showing 1 - 25 of 2,708
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Malignant Glioma, Brain Glioblastoma Trial in United States (OKN-007, Temozolomide (TMZ))

Recruiting
  • Recurrent Malignant Glioma
  • Brain Glioblastoma
  • Birmingham, Alabama
  • +12 more
Aug 18, 2022

Long Covid Trial in Berlin, Cologne, Münster (BC 007 or matching )

Recruiting
  • Long Covid
  • BC 007 or matching placebo
  • Berlin, Germany
  • +3 more
Jun 16, 2023

Cardiomyopathy, Dilated, Heart Failure, Autoantibodies Trial in Belgrade, Belgrad (BC 007)

Active, not recruiting
  • Cardiomyopathy, Dilated
  • +2 more
  • BC 007
  • Belgrade, Serbia
  • +2 more
Jul 19, 2022

Glioblastoma Trial in Oklahoma City (OKN 007, Temozolomide, Photon/Proton IMRT)

Recruiting
  • Glioblastoma
  • OKN 007
  • +2 more
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center, University of Oklahoma Health Sciences
Jun 17, 2022

Migraine, Migraine With Aura, Migraine Without Aura Trial in United States (Dihydroergotamine, Placebo)

Completed
  • Migraine
  • +2 more
  • Chandler, Arizona
  • +126 more
Nov 14, 2022

Epidermolysis Bullosa Dystrophica, Recessive Trial in Stanford, Aurora (FCX-007)

Active, not recruiting
Has Results
  • Epidermolysis Bullosa Dystrophica, Recessive
  • FCX-007
  • Stanford, California
  • +1 more
Sep 30, 2021

Cognitive Impairment Associated With Schizophrenia (CIAS), Cognitive Impairment, Schizophrenia Trial in Garden Grove (RL-007,

Recruiting
  • Cognitive Impairment Associated With Schizophrenia (CIAS)
  • +2 more
  • Garden Grove, California
    Collaborative Neuroscience Research
Jan 8, 2023

Metastatic NSCLC Trial in Worldwide (Pembrolizumab/Vibostolimab, Carboplatin, Cisplatin)

Recruiting
  • Metastatic Non-Small Cell Lung Cancer
  • Pembrolizumab/Vibostolimab
  • +6 more
  • Colorado Springs, Colorado
  • +134 more
Jan 27, 2023

Cancer Patient Perspectives During COVID-19

Active, not recruiting
  • Breast Cancer
    • Aurora, Colorado
      Colorado Research Center
    Nov 17, 2022

    Alopecia Areata (AA) Trial in Canada, United States (IMG-007)

    Recruiting
    • Alopecia Areata (AA)
    • Lomita, California
    • +8 more
    Sep 27, 2023

    Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Los Angeles, Newport Beach (Laboratory Biomarker

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • Refractory Malignant Solid Neoplasm
    • Laboratory Biomarker Analysis
    • +2 more
    • Los Angeles, California
    • +1 more
    Dec 8, 2022

    Colorectal Cancer Trial in Worldwide (favezelimab/pembrolizumab, regorafenib, TAS-102)

    Active, not recruiting
    • Colorectal Cancer
    • favezelimab/pembrolizumab
    • +2 more
    • Washington, District of Columbia
    • +151 more
    Oct 12, 2022

    RSV Infection Trial in Worldwide (MK-1654, Palivizumab, Placebo)

    Recruiting
    • RSV Infection
    • Clesrovimab
    • +2 more
    • Long Beach, California
    • +129 more
    Jan 25, 2023

    Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis, AD Trial in United States (IMG-007)

    Recruiting
    • Atopic Dermatitis
    • +2 more
    • Miami, Florida
    • +3 more
    Aug 9, 2023

    Agitation in Dementia, Including Alzheimer's Disease Trial in United States (ITI-007, Placebo)

    Terminated
    Has Results
    • Agitation in Dementia, Including Alzheimer's Disease
    • Sun City, Arizona
    • +25 more
    Jun 8, 2021

    Transmission and Epidemiology -Prospective Follow-up of

    Recruiting
    • Mpox
      • Tunda, Maniema, Congo, The Democratic Republic of the
        Tunda
      Nov 14, 2023

      Acute Ischemic Stroke Trial in United States (PP-007, Standard of care)

      Completed
      • Acute Ischemic Stroke
      • PP-007
      • Standard of care
      • Jacksonville, Florida
      • +3 more
      Oct 1, 2022

      Classic Galactosemia Trial in Berlin (AT-007)

      Active, not recruiting
      • Classic Galactosemia
      • Berlin, New Jersey
        Hassman Research Institute
      Jun 9, 2022

      Lymphoma, Large B-Cell, Diffuse (DLBCL) Trial in Jerusalem, Seoul, Warszawa (Zilovertamab Vedotin, Cyclophosphamide,

      Recruiting
      • Lymphoma, Large B-Cell, Diffuse (DLBCL)
      • Zilovertamab Vedotin
      • +6 more
      • Victoria, British Columbia, Canada
      • +19 more
      Jan 19, 2023

      Necrotic Pulp Trial (Root canal instrumentation EdgeFile X7 to size #35/0.06, Root canal instrumentation EdgeFile X7 to size

      Not yet recruiting
      • Necrotic Pulp
      • Root canal instrumentation EdgeFile X7 to size #35/0.06
      • +3 more
      • (no location specified)
      Nov 16, 2022

      Study for Patients Treat With WU-CART-007

      Enrolling by invitation
      • T-cell Acute Lymphoblastic Leukemia
      • T-cell Lymphoblastic Lymphoma
      • Genetic: WU-CART-007
      • Saint Louis, Missouri
        Washington University
      Aug 18, 2022

      Advanced Melanoma Trial in China (LBL-007, Toripalimab, Axitinib Tablets)

      Recruiting
      • Advanced Melanoma
      • Beijing, Beijing, China
      • +7 more
      Jan 9, 2023

      Healthy Subject Trial in Chengdu (GS3-007 oral liquid)

      Not yet recruiting
      • Healthy Subject
      • GS3-007 oral liquid
      • Chengdu, Sichuan, China
        Chengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
      Jun 16, 2023

      Acute Myeloid Leukemia Trial in United States (ERAS-007, ERAS-601, Gilteritinib)

      Withdrawn
      • Acute Myeloid Leukemia
      • San Francisco, California
      • +3 more
      Jun 13, 2022

      Advanced Solid Tumor, Metastatic Cancer Trial in Miranda, Clayton, Heidelberg (AU-007, Aldesleukin)

      Recruiting
      • Advanced Solid Tumor
      • Metastatic Cancer
      • Miranda, New South Wales, Australia
      • +2 more
      Jun 10, 2022